Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Rheumatology Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AbbVie
Genentech
Sanofi
Novartis
Takeda Pharmaceutical
Pfizer
Amgen
Janssen Biotech
Bristol-Myers Squibb Company
By Type:
Uric Acid Drugs
Nonsteroidal Anti-inflammatory Drugs
Others
Disease Modifying Anti-rheumatic Drugs
Corticosteroids
By Application:
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Rheumatology Drugs Market Overview 2018-2029
-
1.1 China Rheumatology Drugs Industry Development Overview
-
1.2 China Rheumatology Drugs Industry Development History
-
1.3 China Rheumatology Drugs Industry Market Size (2018-2029)
-
1.4 China Rheumatology Drugs Market Analysis by Type from Production Side
-
1.4.1 China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Uric Acid Drugs (2018-2029)
-
1.4.2 China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Nonsteroidal Anti-inflammatory Drugs (2018-2029)
-
1.4.3 China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.4 China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Disease Modifying Anti-rheumatic Drugs (2018-2029)
-
1.4.5 China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Corticosteroids (2018-2029)
-
1.5 China Rheumatology Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Rheumatology Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)
-
1.5.2 China Rheumatology Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacy (2018-2029)
-
1.5.3 China Rheumatology Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)
-
1.6 China Rheumatology Drugs Market Analysis by Region
-
1.6.1 North China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Rheumatology Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Rheumatology Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Rheumatology Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Rheumatology Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Rheumatology Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Rheumatology Drugs Industry Development
Chapter 3 Rheumatology DrugsIndustry Chain Analysis
-
3.1 Rheumatology Drugs Industry Chain
-
3.2 Rheumatology Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Rheumatology Drugs Market
-
3.3 Rheumatology Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Rheumatology Drugs Market
Chapter 4 China Rheumatology Drugs Market, by Type
-
4.1 China Rheumatology Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Rheumatology Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Rheumatology Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Rheumatology Drugs Production Volume and Growth Rate of Uric Acid Drugs
-
4.5.2 China Rheumatology Drugs Production Volume and Growth Rate of Nonsteroidal Anti-inflammatory Drugs
-
4.5.3 China Rheumatology Drugs Production Volume and Growth Rate of Others
-
4.5.4 China Rheumatology Drugs Production Volume and Growth Rate of Disease Modifying Anti-rheumatic Drugs
-
4.5.5 China Rheumatology Drugs Production Volume and Growth Rate of Corticosteroids
Chapter 5 China Rheumatology Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Rheumatology Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Rheumatology Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Rheumatology Drugs Market Size and Growth Rate of Hospital Pharmacy
-
5.5.2 China Rheumatology Drugs Market Size and Growth Rate of Online Pharmacy
-
5.5.3 China Rheumatology Drugs Market Size and Growth Rate of Retail Pharmacy
Chapter 6 China Rheumatology Drugs Market, by Region
-
6.1 China Rheumatology Drugs Production Volume and Production Value, by Region
-
6.2 China Rheumatology Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Rheumatology Drugs Market Analysis
-
7.1 North China Rheumatology Drugs Market, by Type
-
7.2 North China Rheumatology Drugs Market, by Application
Chapter 8 Central China Rheumatology Drugs Market Analysis
-
8.1 Central China Rheumatology Drugs Market, by Type
-
8.2 Central China Rheumatology Drugs Market, by Application
Chapter 9 South China Rheumatology Drugs Market Analysis
-
9.1 South China Rheumatology Drugs Market, by Type
-
9.2 South China Rheumatology Drugs Market, by Application
Chapter 10 East China Rheumatology Drugs Market Analysis
-
10.1 East China Rheumatology Drugs Market, by Type
-
10.2 East China Rheumatology Drugs Market, by Application
Chapter 11 Northeast China Rheumatology Drugs Market Analysis
-
11.1 Northeast China Rheumatology Drugs Market, by Type
-
11.2 Northeast China Rheumatology Drugs Market, by Application
Chapter 12 Southwest China Rheumatology Drugs Market Analysis
-
12.1 Southwest China Rheumatology Drugs Market, by Type
-
12.2 Southwest China Rheumatology Drugs Market, by Application
Chapter 13 Northwest China Rheumatology Drugs Market Analysis
-
13.1 Northwest China Rheumatology Drugs Market, by Type
-
13.2 Northwest China Rheumatology Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 AbbVie
-
14.1.1 AbbVie Company Profile
-
14.1.2 AbbVie Rheumatology Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Genentech
-
14.2.1 Genentech Company Profile
-
14.2.2 Genentech Rheumatology Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanofi
-
14.3.1 Sanofi Company Profile
-
14.3.2 Sanofi Rheumatology Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Novartis
-
14.4.1 Novartis Company Profile
-
14.4.2 Novartis Rheumatology Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Takeda Pharmaceutical
-
14.5.1 Takeda Pharmaceutical Company Profile
-
14.5.2 Takeda Pharmaceutical Rheumatology Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Pfizer
-
14.6.1 Pfizer Company Profile
-
14.6.2 Pfizer Rheumatology Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Amgen
-
14.7.1 Amgen Company Profile
-
14.7.2 Amgen Rheumatology Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Janssen Biotech
-
14.8.1 Janssen Biotech Company Profile
-
14.8.2 Janssen Biotech Rheumatology Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Bristol-Myers Squibb Company
-
14.9.1 Bristol-Myers Squibb Company Company Profile
-
14.9.2 Bristol-Myers Squibb Company Rheumatology Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Rheumatology Drugs Industry Research Conclusions
-
15.2 Rheumatology Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Rheumatology Drugs Industry Market Size (2018-2029)
-
Figure China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Uric Acid Drugs (2018-2029)
-
Figure China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Nonsteroidal Anti-inflammatory Drugs (2018-2029)
-
Figure China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Disease Modifying Anti-rheumatic Drugs (2018-2029)
-
Figure China Rheumatology Drugs Production Volume, Production Value and Growth Rate of Corticosteroids (2018-2029)
-
Figure China Rheumatology Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)
-
Figure China Rheumatology Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacy (2018-2029)
-
Figure China Rheumatology Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)
-
Figure North China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Rheumatology Drugs Market Size and Growth Rate from 2018-2029
-
Figure Rheumatology Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Rheumatology Drugs Market Share by Type in 2018
-
Figure China Rheumatology Drugs Market Share by Type in 2023
-
Figure China Rheumatology Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Rheumatology Drugs Production Volume and Growth Rate of Uric Acid Drugs (2018-2023)
-
Figure China Rheumatology Drugs Production Volume and Growth Rate of Nonsteroidal Anti-inflammatory Drugs (2018-2023)
-
Figure China Rheumatology Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Rheumatology Drugs Production Volume and Growth Rate of Disease Modifying Anti-rheumatic Drugs (2018-2023)
-
Figure China Rheumatology Drugs Production Volume and Growth Rate of Corticosteroids (2018-2023)
-
Figure China Rheumatology Drugs Market Share by Application in 2018
-
Figure China Rheumatology Drugs Market Share by Application in 2023
-
Figure China Rheumatology Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Rheumatology Drugs Market Size and Growth Rate of Hospital Pharmacy (2018-2023)
-
Figure China Rheumatology Drugs Market Size and Growth Rate of Online Pharmacy (2018-2023)
-
Figure China Rheumatology Drugs Market Size and Growth Rate of Retail Pharmacy (2018-2023)
-
Table China Rheumatology Drugs Production Volume by Region (2018-2023)
-
Table China Rheumatology Drugs Production Volume Share by Region (2018-2023)
-
Figure China Rheumatology Drugs Production Volume Share by Region (2018-2023)
-
Table China Rheumatology Drugs Production Value by Region (2018-2023)
-
Table China Rheumatology Drugs Production Value Share by Region (2018-2023)
-
Figure China Rheumatology Drugs Production Value Share by Region (2018-2023)
-
Table China Rheumatology Drugs Sales Volume by Region (2018-2023)
-
Table China Rheumatology Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Rheumatology Drugs Sales Volume Share by Region (2018-2023)
-
Table China Rheumatology Drugs Sales Value by Region (2018-2023)
-
Table China Rheumatology Drugs Sales Value Share by Region (2018-2023)
-
Figure China Rheumatology Drugs Sales Value Share by Region (2018-2023)
-
Table North China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table North China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table North China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table North China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table Central China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table Central China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table South China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table South China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table South China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table East China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table East China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table East China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Rheumatology Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Rheumatology Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Rheumatology Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Rheumatology Drugs Sales Volume Share by Application (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Genentech Company Profile
-
Table Genentech Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Profile
-
Table Takeda Pharmaceutical Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Janssen Biotech Company Profile
-
Table Janssen Biotech Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Rheumatology Drugs Revenue, Price and Gross (2018-2023)
-
